tirzepatide inline Eli Lilly Launches Self-Pay Vials of for Patients With Obesity Most Successful Weight Loss Program. Compounded Tirzepatide 2 Month Program

It is important to understand that compounded tirzepatide products have not undergone the extensive testing required for FDA approval like Zepbound and Mounjaro have

Gastrointestinal effects dominate: nausea (1722%), diarrhea (1316%), vomiting (610%), decreased appetite (79%), and indigestion (~7%)

Is not safe for people with serious heart rhythm problems, recent stroke, severe liver disease, uncontrolled psychiatric conditions, or a history of severe hypoglycemia

Skelley J

During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules